This contract supports the development of safe and effective MCMs to mitigate and/or treat tissue injuries arising from exposure to ionizing radiation from a radiological or nuclear incident, thereby leading to a reduction in radiation-associated morbidities and mortalities.
IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
-
Activity
N01
-
Administering IC
AI
-
Application Type
-
Direct Cost Amount
-
Indirect Cost Amount
-
Total Cost
1773102
-
Sub Project Total Cost
-
ARRA Funded
False
-
CFDA Code
-
Ed Inst. Type
-
Funding ICs
OD:1773102\
-
Funding Mechanism
Non SBIR/STTR Contracts
-
Study Section
-
Study Section Name